FGFR inhibitors combined with nab-paclitaxel - A promising strategy to treat non-small cell lung cancer and overcome resistance

Feng Ma(Hebei North University), Meng Xu(First Affiliated Hospital of Jinan University)
Frontiers in Oncology
February 10, 2023
Cited by 4


Related Papers